The European Society for Immunodeficiencies hosted the ESID 2024 meeting in sunny Marseille, France, from 16-19 October. We were proud to have our Senior Scientist, Shiva Dahal-Koirala, give a talk during the event. 😊
The theme for this 21st biennial meeting was “Human Inborn Errors of Immunity: An Expanding Universe”. The program brought global experts to share the latest advancements in diagnosing, treating, and managing inborn errors of immunity (IEI) through lectures, workshops, and interactive sessions.
The abstract submitted by Shiva was titled CRISPR/Cas9-based autologous T cell editing pipeline for Inborn Errors of Immunity, and was chosen for a talk in the Oral communications session focusing on therapies.
